Saturday, July 11, 2026

Drug profile · INN

florbetapir (18f)

florbetapir (18f) (AMYVID) is a diagnostic agent.

EMA: approved Various (V09) V09AX05
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — florbetapir (18f)
Class
Various (V09)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

florbetapir (18f) (AMYVID) is a diagnostic agent.

Key facts

INN florbetapir (18f)
Brand AMYVID
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09AX05

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. C24-50 Phase 3 · George Institute for · Semantic Variant Primary Progressive Aphasia, Alcohol Use Di
  2. I5T-MC-AACI Phase 2 · Eli Lilly and · Alzheimer Disease
  3. Florbetapir F 18 (18F-AV-45) Approved · BRIGHT MINDS BIOSCIENCES · Postoperative Cognitive Dysfunction

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is florbetapir (18f)?

florbetapir (18f) (AMYVID) is a diagnostic agent.

What is the brand name for florbetapir (18f)?

AMYVID is a marketed brand name for florbetapir (18f). Check FDA Drugs@FDA for the current US label holder and prescribing information.